PERK mediates resistance to BRAF inhibition in melanoma with impaired PTENYifei Qin(Institute of Urban Environment), Yanlin Yu(National Institutes of Health)npj Precision OncologyJuly 19, 202110.1038/s41698-021-00207-xCited by 23SaveCiteExport RISWatch citationsRelated PapersPTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression|Cancers|2022|57